Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials
| dc.contributor.author | Clowse, Megan E. B. | |
| dc.contributor.author | Wallace, Daniel | |
| dc.contributor.author | Furie, Richard A. | |
| dc.contributor.author | Petri, Michelle A. | |
| dc.contributor.author | Pike, Marilyn C. | |
| dc.contributor.author | Leszczyński, Piotr | |
| dc.contributor.author | Neuwelt, C. Michael | |
| dc.contributor.author | Hobbs, Kathryn | |
| dc.contributor.author | Keiserman, Mauro | |
| dc.contributor.author | Duca, Liliana | |
| dc.contributor.author | Kalunian, Kenneth C. | |
| dc.contributor.author | Galateanu, Catrinel | |
| dc.contributor.author | Bongardt, Sabine | |
| dc.contributor.author | Stach, Christian | |
| dc.contributor.author | Beaudot, Carolyn | |
| dc.contributor.author | Kilgallen, Brian | |
| dc.contributor.author | Gordon, Caroline | |
| dc.contributor.author | Szűcs, Gabriella | |
| dc.date.accessioned | 2018-03-12T13:06:31Z | |
| dc.date.available | 2018-03-12T13:06:31Z | |
| dc.date.issued | 2017 | |
| dc.date.oa | 2018-06-06 | |
| dc.date.pasync | 2018-05-18T00:30:30Z | |
| dc.date.updated | 2018-05-18T00:30:30Z | |
| dc.description.corrector | LB | |
| dc.identifier.citation | Arthritis & Rheumatology. - 69 : 2 (2017), p. 362-375. -Arthritis & Rheumatology. - 2326-5191 | |
| dc.identifier.doi | http://dx.doi.org/10.1002/art.39856 | |
| dc.identifier.issn | 2326-5191 | |
| dc.identifier.opac | http://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM072674 | |
| dc.identifier.uri | http://hdl.handle.net/2437/248621 | |
| dc.identifier.url | http://doi.wiley.com/10.1002/art.39856 | |
| dc.language | eng | |
| dc.rights.access | open access article | |
| dc.rights.cc | CC BY-NC 3.0 | |
| dc.rights.owner | szerzők | |
| dc.rights.owner | Wiley | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc/3.0/ | |
| dc.subject.mab | Orvostudományok | |
| dc.subject.mab | Klinikai orvostudományok | |
| dc.title | Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials | |
| dc.type | folyóiratcikk |
Fájlok
Eredeti köteg (ORIGINAL bundle)
1 - 1 (Összesen 1)
Nincs kép
- Név:
- FILE_UP_0_Embody 2017.pdf
- Méret:
- 352.43 KB
- Formátum:
- Adobe Portable Document Format
- Leírás:
- kiadói változat